Consumer Defensive
Live Price
Offline$0.36
-0.04% today
1Y Change
+42.46%
Window
Jun 23, 2025 → Jun 16, 2026
Coverage: 247 bars · Jun 23, 2025 → Jun 16, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Pangea Wellness Inc. (PNGAF) is a Consumer Defensive stock with a market cap of $10.00M and listed on OTC. The stock last traded around $0.36 and up 42.5% across the available one-year price window (Jun 23, 2025 → Jun 16, 2026). Baseline metrics include revenue growth of +307.4%, EPS growth of -40.0%, a dividend yield of 0.0%. What stands out right now is revenue +307.4%, EPS -40.0%, free cash flow -429.9% with operating margin -4529.3% and ROIC -242.2%. Valuation already assumes a fairly strong business story at price/sales 184.5. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines PNGAF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Consumer Defensive peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
PNGAF
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
PNGAF Max Drawdown
-57.89%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for PNGAF and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$68.5K
-90.2% YoY
FY Net Income
-$173.2K
+89.2% YoY
Free Cash Flow
-$590.7K
+18.6% YoY
Revenue Growth
+307.4%
EPS Growth
-40.0%
Gross Margin
-48.8%
Net Margin
-9203.1%
Income statement
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 50K | 12K | 286K | 698K | 68K |
| Gross Profit | -69K | 7K | -33K | 41K | -67K |
| Operating Income | -2M | -921K | -2M | -664K | -173K |
| EBITDA | -2M | -917K | -2M | -898K | -172K |
| Net Income | -5M | -1M | -2M | -2M | -173K |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
CAD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 960K | 140K | 52K | 76K | 808K |
| Total Assets | 1M | 182K | 192K | 620K | 1M |
| Total Liabilities | 401K | 733K | 330K | 409K | 117K |
| Shareholder Equity | 930K | -550K | -138K | 212K | 1M |
| Total Debt | 0 | 18K | 0 | 0 | 0 |
| Net Debt | -960K | -122K | -52K | -76K | -808K |
Cash flow positioning
Latest Full Year
Operating Cash Flow
530K
+26.3% YoY
Capital Expenditures
61K
-747.0% YoY
Free Cash Flow
591K
+18.6% YoY
Key ratios
Gross Margin
-48.8%
Operating Margin
-4529.3%
Net Margin
-9203.1%
ROE
-241.9%
Debt / Equity
0.00x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.